Trust is earned

§Survey among 1,002 Eye Care Professionals from the United States, United Kingdom, Japan, South Korea, China, France, and Germany conducted 10/2022 to 11/2022.

*Free trial lenses available from participating eye care professionals. Exam and fitting fees not included.

‡Source Euromonitor International Limited; based on research conducted in Sept-Nov 2022; "world" and "globally" represent markets accounting for 78% of total daily disposable contact lenses in 2021 (retail sales).

+ClinicalTrials.gov is a website maintained by the NIH. The 28 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE^® OASYS Brand 2-week family, ACUVUE^® OASYS 1-Day Brand family, and ACUVUE^® OASYS MAX 1-Day Brand family of contact lenses, vs. competitors’ products. Review conducted as of April 30, 2023.

#Helps protect against transmission of harmful UV radiation to the cornea & into the eye.
WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care professional for more information.

¶JJV Data on File 2016. Statistical superiority on Comfort, Vision, and Handling composite scores achieved using the Contact Lens User Experience (CLUE) questionnaire, a validated patient-reported outcomes (PRO) tool. In two randomized, single (patient) masked, crossover clinical studies (2015, n=119 (Vision & Handling) and 2016, n=276 (Comfort)) patients were randomly assigned ACUVUE OASYS 1-Day with HydraLuxe Technology or Dailies Total1 the first week and switched to wearing the other lens the second week. Lenses were worn as daily disposable on both eyes.

∞Designed to support the functions of the tear film.

†ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE^® OASYS Brand 2-week family contact lenses vs. competitors’ products. Review conducted as of April 30, 2023.

±Calculated per ISO-8980-3 for 380-460nm (Blue Light Hazard Function, β(λ))

Important information for contact lens wearers: ACUVUE^® Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye care professional. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye care professional immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-267-5098, or download the Patient Instruction Guides.

Transitions, the Transitions logo, and Transitions Light intelligent Technology are trademarks of Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.

PP2023AMB5113